1. Home
  2. AN vs BLTE Comparison

AN vs BLTE Comparison

Compare AN & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$212.57

Market Cap

6.4B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$157.73

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AN
BLTE
Founded
1991
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.6B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AN
BLTE
Price
$212.57
$157.73
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$244.33
$198.00
AVG Volume (30 Days)
303.6K
117.4K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
0.71
N/A
EPS
17.04
N/A
Revenue
$27,631,400,000.00
N/A
Revenue This Year
$4.32
N/A
Revenue Next Year
$2.89
$492.11
P/E Ratio
$12.08
N/A
Revenue Growth
3.24
N/A
52 Week Low
$173.26
$56.68
52 Week High
$228.92
$200.00

Technical Indicators

Market Signals
Indicator
AN
BLTE
Relative Strength Index (RSI) 65.75 43.63
Support Level $203.90 $157.63
Resistance Level $224.10 $161.28
Average True Range (ATR) 6.16 6.26
MACD 0.61 -1.15
Stochastic Oscillator 94.98 17.27

Price Performance

Historical Comparison
AN
BLTE

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: